812
Views
2
CrossRef citations to date
0
Altmetric
Coronavirus

A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences

ORCID Icon, , , , , , , , , , , , , , , , & show all
Article: 2240690 | Received 10 May 2023, Accepted 20 Jul 2023, Published online: 08 Aug 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)